Skip to main navigation
Live - Corporate Menu
about prevail
about us
executive team
board of directors
partners
our science
overview
lysosomal dysfunction
gene therapy
PD-GBA
gaucher disease
FTD-GRN
supporting publications
our programs
our pipeline
PR001
PR006
PR004
patients
investors & media
overview
press releases
events & presentations
corporate governance
sec filings
stock information
email alerts
investor contacts
careers
contact us
Investor Relations
Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Email Alerts
Investor Contacts
Event Details
Guggenheim Healthcare Talks Idea Forum 2nd Annual Neuro/Immunology Day
Nov 16, 2020
Top
